Chronic Plaque PsoriasisNCT00799877
Chronic Plaque Psoriasis (Ps) Registry
An observational study of Chronic Plaque Psoriasis, run by AbbVie at 339 sites in 14 countries.
Trial summary
The purpose of this study is to evaluate the long-term safety of Humira® in Adult Patients with Chronic Plaque Psoriasis (Ps). Read more about this study
- Who is it for?
- Ages 18 to 99 years
- Conditions the study is for
- Chronic Plaque Psoriasis
- How many people
- 6,065 participants
- Where
- 339 sitesin 14 countries
- Study dates
- 26 Sep 2008to 13 Feb 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 99 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: primary care clinic, departments of dermatology
Who may be able to join
- An adult patient (18 years of age or older) with chronic plaque psoriasis who has been prescribed HUMIRA® therapy according to the local product labeling and meets one of the following criteria:
- New initiated (within 4 weeks of registry entry) on HUMIRA® therapy;
- Initiated HUMIRA® therapy in the past and:
- Has received continuous (no more than 70 consecutive days off drug) HUMIRA® therapy and the physician can provide source documentation of SAEs, AEs, of Special Interest, and dosing information since initiation of therapy.
- OR
- Is entering after participation in an AbbVie HUMIRA (adalimumab) sponsored study and has received continuous (no more than 70 consecutive days off drug) HUMIRA® therapy after the completion of AbbVie sponsored study and physician can provide source documentation of SAEs, AEs of Special Interest, and dosing information since initiation of commercial HUMIRA® (defined as a prescribed/non study drug).
- Patient is willing to consent to data being collected and provided to AbbVie;
- Patient is capable of and willing to give written informed consent and to comply with the requirements of the registry.
Who cannot join
- Patient should not be enrolled if he/she cannot be treated in accordance with the local product label.
Trial locations and contacts
339 sites in 14 countries.
339 sites in 14 countries
United States222 sites
Hawkins, Akron, Ohio /ID# 28149
Akron, Ohio, 44313
Summa Physicians Dermatology /ID# 37051
Akron, Ohio, 44320
Hamilton Research, LLC /ID# 20503
Alpharetta, Georgia, 30022
David Fivenson, MD, PLC /ID# 20504
Ann Arbor, Michigan, 48103
Anapolis Dermatology Center /ID# 24302
Annapolis, Maryland, 21409
Dermatology Assoc of WI /ID# 28142
Appleton, Wisconsin, 54913
Arlington Research Center, Inc /ID# 23063
Arlington, Texas, 76011
Premier Dermatology /ID# 69958
Ashburn, Virginia, 20147-5667
Oakview Dermatology, LLC /ID# 38298
Athens, Ohio, 45701-2866
Parker, Atlanta, GA /ID# 40190
Atlanta, Georgia, 30322-1013
Reflections Dermatology & Psoriasis canter /ID# 19781
Auburn, New York, 13021
Austin Dermatology Associates /ID# 38296
Austin, Texas, 78705
Steiner Ranch Dermatology /ID# 20509
Austin, Texas, 78732-6067
Austintown /ID# 76121
Austintown, Ohio, 44515
Private Practice- Dr. Tory Sullivan /ID# 17126
Aventura, Florida, 33180
MidSouth Dermatology /ID# 17128
Bartlett, Tennessee, 38134
The Dermatology Center, PSC - Bayside NY /ID# 28170
Bayside, New York, 11360
Mikell, Beaufort, SC /ID# 17143
Beaufort, South Carolina, 29902
Belleville Dermatology Center /ID# 17067
Belleville, New Jersey, 07109
Dermatology & Laser Center NW /ID# 18324
Bellingham, Washington, 98225
Glassman, Bethesda, MD /ID# 17069
Bethesda, Maryland, 20817
Southview Medical Group, PC /ID# 20961
Birmingham, Alabama, 35205
Total Skin and Beauty Derm Ctr /ID# 17156
Birmingham, Alabama, 35205
Inverness Dermatology /ID# 76194
Birmingham, Alabama, 35242
McLain Medical Associates, PC /ID# 18351
Birmingham, Alabama, 35242
Wray, Blackfoot, ID /ID# 24333
Blackfoot, Idaho, 83221
Brigham Dermatology Associates /ID# 28207
Boston, Massachusetts, 02115
Moss and Maiocco, MD, LLC /ID# 69767
Bridgeport, Connecticut, 06606
Saoud, Bridgeport, WV /ID# 17135
Bridgeport, West Virginia, 26330
Skin Cancer & Cosmetic Derm Ct /ID# 23313
Calhoun, Georgia, 30701
Shideler Dermatology Group /ID# 69957
Carmel, Indiana, 46032
Dermatology and Skin Surgery /ID# 88353
Celebration, Florida, 34747
Central Dermatology Center, PA /ID# 17070
Chapel Hill, North Carolina, 27517-8913
Dr. Aida Lugo-Somolinos /ID# 24309
Chapel Hill, North Carolina, 92037
Hampton, Charleston, NC /ID# 18865
Charleston, South Carolina, 29407
Coastal Clinical Research Center of the Carolinas /ID# 18353
Charleston, South Carolina, 29414
Fraser, Charlotte, NC /ID# 19772
Charlotte, North Carolina, 28207
Pinski Dermatology /ID# 17147
Chicago, Illinois, 60602
Northwestern University Feinberg School of Medicine /ID# 28169
Chicago, Illinois, 60611-2927
John H. Stroger, Jr. Hosp /ID# 40185
Chicago, Illinois, 60612-9985
Rush University Medical Center /ID# 47604
Chicago, Illinois, 60612
Del Campo, Chicago, IL /ID# 19770
Chicago, Illinois, 60641
Idaho Skin Institute /ID# 76118
Chubbuck, Idaho, 83202
Mountain State Clinical Research /ID# 28146
Clarksburg, West Virginia, 26301
Skin Cancer & Cosmetic Derm /ID# 65882
Cleveland, Tennessee, 37311
Iacobelli, Clinton Twnshp, MI /ID# 38290
Clinton Township, Michigan, 48038
Colorado Springs Derm Clinic /ID# 28165
Colorado Springs, Colorado, 80910
The Ohio State University /ID# 43150
Columbus, Ohio, 43210
East Metro Dermatology PC /ID# 20505
Conyers, Georgia, 30012
Florida Academic Centers Research and Education /ID# 24273
Coral Gables, Florida, 33134
Knuckles, Corbin, KY /ID# 17101
Corbin, Kentucky, 40701
Spencer Dermatology Associates /ID# 71678
Crawfordsville, Indiana, 47933
Dermatology Treatment and Research Center /ID# 17545
Dallas, Texas, 75230
Aftergut, Dallas, TX /ID# 17041
Dallas, Texas, 75237
Texas Dermatology Associates /ID# 28155
Dallas, Texas, 75246
Texas Dermatology Associates /ID# 28157
Dallas, Texas, 75246
Notaro, Danbury, CT /ID# 40264
Danbury, Connecticut, 06810
Derm Assoc of Western CT /ID# 71673
Danbury, Connecticut, 23454
Elite MD Adv Derm Laser /ID# 28323
Danville, California, 94526
Deep South Dermatology, PC /ID# 40267
Daphne, Alabama, 36526
Dermatology Associates of the Palm Beaches /ID# 17137
Delray Beach, Florida, 33486
Altoona Ctr Clinical Res /ID# 17155
Duncansville, Pennsylvania, 16635
Duke Cancer Center /ID# 24324
Durham, North Carolina, 27710-3000
Psoriasis Treatment Center of Central New Jersey /ID# 17148
East Windsor, New Jersey, 08520
Allied Dermatology and Skin Surgery /ID# 28154
Fairlawn, Ohio, 44333-4510
Hamzavi Dermatology /ID# 25903
Fort Gratiot, Michigan, 48059
Ft. Lauderdale Derm & Cosmetic /ID# 23071
Fort Lauderdale, Florida, 33308
Johnson Dermatology Clinic /ID# 17088
Fort Smith, Arkansas, 72916-6103
Center for Dermatology Clinical Research /ID# 20722
Fremont, California, 94538
Associates in Research /ID# 17544
Fresno, California, 93720
Garden City Dermatology /ID# 42003
Garden City, New York, 11530
Dermatology and Dermatologic /ID# 17145
Garden Grove, California, 92843
Guagenti, Glendale, CA /ID# 28263
Glendale, California, 91204
Pinnacle Dermatology - Grand Blanc /ID# 40196
Grand Blanc, Michigan, 48439-2443
Stawiski, Grand Rapids, MI /ID# 17124
Grand Rapids, Michigan, 49503
Piedmont Dermatology Center /ID# 18326
Greensboro, North Carolina, 27408
Schwartz,Harlingen,TX,US /ID# 20725
Harlingen, Texas, 78550-8255
Great Plains Dermatology, P.A. /ID# 23079
Hays, Kansas, 67601
Assoc. Derm & Skin Cancer Clin /ID# 24303
Helena, Montana, 59601
Academic Dermatology of Nevada /ID# 20513
Henderson, Nevada, 89052
Fernandez-Obregon, Hoboken, NJ /ID# 23073
Hoboken, New Jersey, 07030
Hollywood Dermatology /ID# 17129
Hollywood, Florida, 33021
Hollywood Dermatology /ID# 19771
Hollywood, Florida, 33021
Sonabend, Houston, TX /ID# 17123
Houston, Texas, 77005
Heights Dermatology & Aesthetic Center /ID# 28325
Houston, Texas, 77008
Memorial Clinical Associates /ID# 17085
Houston, Texas, 77079
West Houston Dermatology /ID# 18330
Houston, Texas, 77082
Northeast Alabama Dermatology /ID# 76193
Huntsville, Alabama, 35801
Yates, Huntsville, AL /ID# 17130
Huntsville, Alabama, 35801
Indiana University /ID# 37052
Indianapolis, Indiana, 46202
Dawes Fretzin, LLC /ID# 17151
Indianapolis, Indiana, 46256
Dawes Fretzin, LLC /ID# 17502
Indianapolis, Indiana, 46256
Dermatology Associates of Indiana /ID# 24269
Indianapolis, Indiana, 46260
Dermatology Associates /ID# 42008
Kingsport, Tennessee, 37660
Miremadi Dermatology /ID# 24323
La Jolla, California, 92037
SCRIPPS Clinic /ID# 28147
La Mesa, California, 91941
Linda Woodson Dermatology /ID# 18333
Las Vegas, Nevada, 89128-0652
Nathan Adelson Hospice /ID# 18332
Las Vegas, Nevada, 89128
Bruckstein, Lawrence, NY /ID# 17063
Lawrence, New York, 11559
Dartmouth-Hitchcock Medical Center /ID# 20502
Lebanon, New Hampshire, 03756
Suncoast Dermatology and Skin Surgery Center /ID# 23067
Lecanto, Florida, 34461
Lakeside Dermatology /ID# 247839
Libertyville, Illinois, 60048-1307
Dr. Abdallah Khourdaji /ID# 24307
Lodi, California, 95242
Premiere Clinical Research,LLC /ID# 44719
Long Beach, California, 90712
Skin Care Specialists of CO /ID# 17142
Longmont, Colorado, 80501
Kaiser Permanente LA Med Ctr /ID# 24334
Los Angeles, California, 90027
Dermatology Research Associates /ID# 17158
Los Angeles, California, 90045
Lehman Dermatology Clinic /ID# 17082
Lubbock, Texas, 79410
Texas Tech University Health Sciences Center - Lubbock /ID# 37050
Lubbock, Texas, 79430
Dermatologic Surgery Specialis /ID# 17149
Macon, Georgia, 31217
NW GA Dermatology & Skin Cancer Specialists /ID# 17089
Marietta, Georgia, 30060
Paula Nelson MD & Associates /ID# 23076
Marietta, Georgia, 30067
Loyola University Medical Ctr /ID# 23065
Maywood, Illinois, 60153
The Dermatology Inst of S. TX /ID# 38288
McAllen, Texas, 78501
Athenea Assoc Med Research /ID# 69768
Miami, Florida, 33126
Mobile Dermatology, P.C. /ID# 19783
Mobile, Alabama, 36609
Hardy County Medical /ID# 28264
Moorefield, West Virginia, 26836
Fulk, Morristown, TN /ID# 18344
Morristown, New Jersey, 37814
California Skin Institute /ID# 19769
Mountain View, California, 94040
Saltzer Medical Group /ID# 17144
Nampa, Idaho, 83687
Assoc. in Med & Surg Derm /ID# 17523
Naples, Florida, 34109
Nashua Dermatology /ID# 18352
Nashua, New Hampshire, 03060-3956
The Dermatology Center PSC - New Albany /ID# 20501
New Albany, Indiana, 47150
Dermatology Associates of Coastal Carolina /ID# 76116
New Bern, North Carolina, 28560
Choi, New Haven, CT /ID# 58982
New Haven, Connecticut, 06510
Scheinfeld, New York, NY /ID# 17136
New York, New York, 10019
New York Presbyterian Hospital Weill Cornell Medical Center /ID# 24268
New York, New York, 10065
Panzer Dermatology & Cosmetic /ID# 17131
Newark, Delaware, 19713
Panzer Dermatology & Cosmetic /ID# 17146
Newark, Delaware, 19713
RI Dermatology & Cosmetic Ctr /ID# 40270
Newport, Georgia, 02840
Quest Dermatology Research /ID# 71677
Northridge, California, 91324-4663
Lakeshore Dermatology /ID# 24330
Norton Shores, Michigan, 49444-7831
South Nassau Dermatology /ID# 17065
Oceanside, New York, 11572
Univ Oklahoma HSC /ID# 28145
Oklahoma City, Oklahoma, 73104
Center of Dermatology, P.C. /ID# 23078
Omaha, Nebraska, 68114
Central Florida Dermatology Associates /ID# 20508
Orlando, Florida, 32806
Epiphany Dermatology of Kansas LLC /ID# 19764
Overland Park, Kansas, 66210
Dermatology Medical Group of Oxnard /ID# 17102
Oxnard, California, 93030
Gulf Coast Dermatology /ID# 20724
Panama City, Florida, 32405
Snyder, Pembroke Pines, FL /ID# 17122
Pembroke Pines, Florida, 33028
Medical Dermatology Specialist /ID# 76113
Phoenix, Arizona, 85006-2722
Arizona Advanced Dermatology /ID# 20512
Phoenix, Arizona, 85014
Camelback Dermatology & Skin Surgery /ID# 18901
Phoenix, Arizona, 85018
Alliance Dermatology and MOHs Center, PC /ID# 17087
Phoenix, Arizona, 85032
Omni Dermatology Research /ID# 135562
Phoenix, Arizona, 85108
Carolina Skin Care /ID# 19773
Pinehurst, North Carolina, 28374
Gary L. Heller - Dermatology Research Cosmetic Center /ID# 17083
Pinellas Park, Florida, 33781
University of Pittsburgh MC /ID# 17068
Pittsburgh, Pennsylvania, 15260
The Indiana Clinical Trials Center /ID# 17153
Plainfield, Indiana, 46168
Skin and Cancer Associates /ID# 20726
Plantation, Florida, 33324-1857
Great Lakes Dermatology /ID# 17061
Pleasant Prairie, Wisconsin, 53158
Great Lakes Dermatology /ID# 91433
Pleasant Prairie, Wisconsin, 53158
Oregon Dermatology and Research Center /ID# 24327
Portland, Oregon, 97210
Oregon Medical Research Center /ID# 28143
Portland, Oregon, 97239
Andrus and Assoc Dermatology /ID# 20510
Raleigh, North Carolina, 27609
Riley, Reno, NV /ID# 36343
Reno, Nevada, 89509
Aylesworth, Rhinelander, WI /ID# 18322
Rhinelander, Wisconsin, 54501
The Ctr for Derm at Lifetime /ID# 47603
Rochester, New York, 14623
Dermatology and Skin Cancer Specialists, LLC /ID# 65884
Rockville, Maryland, 20850
Boice-Willis Clinic, P.A. /ID# 17125
Rocky Mount, North Carolina, 27804
Hull Dermatology, PA /ID# 17086
Rogers, Arkansas, 72758
Arlington Dermatology /ID# 23062
Rolling Meadows, Illinois, 60008
Skin Cancer & Cosmetic Derm /ID# 24305
Rome, Georgia, 30161
Northwest Georgia Dermatology /ID# 28162
Rome, Georgia, 30165
Dermatology Associates of San Antonio /ID# 17150
San Antonio, Texas, 78258
Univ California, San Francisco /ID# 28267
San Francisco, California, 94143-2204
Danesh, San Gabriel, CA /ID# 23068
San Gabriel, California, 91776
Carson, San Jose, CA /ID# 17064
San Jose, California, 95123
East Bay Psoriasis Trmnt Ctr /ID# 17081
San Ramon, California, 94583
Redwood Family Dermatology /ID# 76119
Santa Rosa, California, 95403
The Center for Skin Wellness /ID# 42005
Sarasota, Florida, 34240
Schaumburg Dermatology, SC /ID# 38294
Schaumburg, Illinois, 60173
Affiliated Dermatology /ID# 18327
Scottsdale, Arizona, 85255
Dermatology Associates of Seattle /ID# 18328
Seattle, Washington, 98101
Dermatology Associates of Seattle /ID# 19802
Seattle, Washington, 98101
Shoreline Skin Specialists, SC /ID# 69771
Sheboygan, Wisconsin, 53081-3043
Dermedx Dermatology, PC /ID# 28163
Smithtown, New York, 11787
UMDNJ R. W. Johnson Med School /ID# 24326
Somerset, New Jersey, 08873
Aspen Dermatology, PLLC /ID# 38293
Spanish Fork, Utah, 84660
Aspen Dermatology, PLLC /ID# 40183
Spanish Fork, Utah, 84660
Aspen Dermatology, PLLC /ID# 40192
Spanish Fork, Utah, 84660
Westside Dermatology, LLC /ID# 17541
Spartanburg, South Carolina, 29306
Premier Clinical Research /ID# 28168
Spokane, Washington, 99202
St. Louis University /ID# 28150
St Louis, Missouri, 63104
Metro Hypertension and Kidney /ID# 40184
St Louis, Missouri, 63136
Dermatology Associates, Inc. /ID# 23075
St Louis, Missouri, 63141
Water's Edge Dermatology - Stuart /ID# 76114
Stuart, Florida, 34994
Derm Consultants of Summit /ID# 24308
Summit, New Jersey, 07901-2571
Komorous, Tacoma, WA /ID# 42007
Tacoma, Washington, 98405
Scannon, Tampa, Florida /ID# 28160
Tampa, Florida, 33607
University of South Florida /ID# 38289
Tampa, Florida, 33612
Ctr for Derm & Skin Surgery /ID# 28210
Tampa, Florida, 33613
Geisinger Medical Center /ID# 17521
Tampa, Florida, 33618
Tucker, The Woodlands, Texas /ID# 38295
The Woodlands, Texas, 77380
Kansas Medical Clinic /ID# 28212
Topeka, Kansas, 66614
Somerset Skin Centre /ID# 17157
Troy, Michigan, 48084
Atlanta Derm & Laser Surgery /ID# 28144
Tucker, Georgia, 30084
Specialists in Dermatology /ID# 18864
Tucson, Arizona, 85712
Tulsa Dermatology Clinic, Inc. /ID# 71675
Tulsa, Oklahoma, 74114
Olmstead, Twin Falls, ID /ID# 24325
Twin Falls, Idaho, 83301
Skin and Laser Surgery Center /ID# 40182
Tysons Corner, Virginia, 22182
Skin Physicians & Surgeons Med /ID# 40265
Upland, California, 91786
Advanced Dermatology & Cosmetic Care /ID# 20511
Valencia, California, 91355
Solano Dermatology Associates /ID# 20727
Vallejo, California, 94590
Coast Derm & Skin Cancer Ctr /ID# 40189
Venice, Florida, 34293
Heskel, Vero Beach, FL /ID# 69764
Vero Beach, Florida, 32960
The Dermatology Group, PC /ID# 28158
Verona, New Jersey, 07044
Tidewater Skin Care/Pathology /ID# 71674
Virginia Beach, Virginia, 23454
Eastern Washington Dermatology /ID# 17542
Walla Walla, Washington, 99362
Brodell Medical Inc. /ID# 24304
Warren, Ohio, 44483
George Washington University Hospital /ID# 24270
Washington D.C., District of Columbia, 20037-2342
DuPage Medical Group /ID# 18861
Wheaton, Illinois, 60189-3801
DuPage Medical Group /ID# 20507
Wheaton, Illinois, 60189-3801
Charles County Dermatology /ID# 18341
White Plains, Maryland, 20695
Town Center Dermatology /ID# 28152
Wildwood, Missouri, 63040
Crane, Wilmington, NC /ID# 17066
Wilmington, North Carolina, 28401
Wilmington Dermatology Center /ID# 69763
Wilmington, North Carolina, 28403
Polley Clinic of Dermatology /ID# 18334
Wilson, North Carolina, 27893
PMG Research of Winston-Salem /ID# 17133
Winston-Salem, North Carolina, 27103-3921
Mercy Woodstock Medical Center /ID# 40186
Woodstock, Illinois, 60098
Worcester Dermatology Assoc. /ID# 37048
Worcester, Massachusetts, 01698
Marcus, Wyckoff, NJ /ID# 23074
Wyckoff, New Jersey, 07481
Canada28 sites
Kirk Barber Research, CA /ID# 24204
Calgary, Alberta, T2G 1B1
Dr. Isabelle Delorme Inc. /ID# 79193
Drummondville, Quebec, J2B 5L4
Stratica Medical /ID# 24266
Edmonton, Alberta, T5K 1X3
Murray, Halifax, CA /ID# 24224
Halifax, Nova Scotia, B3K 5R3
Dermatrials Research /ID# 18363
Hamilton, Ontario, L8N 1Y2
The Guenther Dermatology Research Centre /ID# 79196
London, Ontario, N6A 3H7
Lynderm Research Inc. /ID# 18362
Markham, Ontario, L3P 1X2
Durondel C.P. Inc. /ID# 28136
Moncton, New Brunswick, E1C 2Z3
Innovaderm Research Inc. /ID# 18866
Montreal, Quebec, H2X 2V1
Entralogix Clinical Research /ID# 79194
Newmarket, Ontario, L3Y 6P5
Entralogix Clinical Research /ID# 79197
Newmarket, Ontario, L3Y 6P5
Bank on Beauty /ID# 24205
Niagara Falls, Ontario, L2E 2R4
North Bay Dermatology Centre /ID# 28138
North Bay, Ontario, P1B 3Z7
SKIN Centre for Dermatology /ID# 79195
Peterborough, Ontario, K9J 5K2
Centre de Dermatologie Maizerets /ID# 20515
Québec, Quebec, G1J 1X7
Centre de Recherche dermatologique du Quebec Metropolitain /ID# 18361
Québec, Quebec, G1V 4X7
Karma Clinical Trials /ID# 37049
St. John's, Newfoundland and Labrador, A1A 4Y3
Alpha Clinical Research Ctr. /ID# 20581
St. John's, Newfoundland and Labrador, A1B 4S8
Nexus Clinical Research /ID# 79198
St. John's, Newfoundland and Labrador, A1B 5E8
NewLab Clinical Research Inc. /ID# 18360
St. John's, Newfoundland and Labrador, A1C 2H5
Dr. Chih-ho Hong Medical Inc. /ID# 40199
Surrey, British Columbia, V3R 6A7
Enverus Medical Research /ID# 141448
Surrey, British Columbia, V3V 0C6
Dr. Jensen Yeung Medicine Professional Corporation /ID# 28141
Toronto, Ontario, M5S 1B2
University of British Columbia - Eye Care Centre, Vancouver General Hospital /ID# 24223
Vancouver, British Columbia, V5Z 3N9
K. Papp Clinical Research /ID# 28137
Waterloo, Ontario, N2J 1C4
Dr. Beatrice Wang /ID# 18359
Westmount, Quebec, H3Z 2S6
XLR8 Medical Research /ID# 28140
Windsor, Ontario, N8W 1E6
Winnipeg Clinic /ID# 37046
Winnipeg, Manitoba, R3C 0N2
France16 sites
CHRU de Besancon - Site Saint-Jacques /ID# 24202
Besançon, 25030
CHRU Tours - Hopital Trousseau /ID# 28271
Chambray-lès-Tours, 37170
CHRU Lille - Hopital Claude Huriez /ID# 37063
Lille, Hauts-de-France, 59037
CHU Limoges - Dupuytren 1 /ID# 25904
Limoges, Franche-Comte, 87042
AP-HM - Hopital Sainte Marguerite /ID# 28270
Marseille, 13009
Hopital Fournier /ID# 27938
Nancy, 54000
CHU de Nantes, Hotel Dieu -HME /ID# 27944
Nantes, Pays de la Loire Region, 44000
Chu de Nice-Hopital L'Archet Ii /Id# 27936
Nice, Alpes-Maritimes, 06200
AP-HP - Hopital Saint-Louis /ID# 24203
Paris, 75010
CHU Bordeaux - Hopital Haut Leveque /ID# 27934
Pessac, Gironde, 33604
HCL - Hopital Lyon Sud /ID# 156129
Pierre-Bénite, Auvergne-Rhône-Alpes, 69495
HCL - Hopital Lyon Sud /ID# 27940
Pierre-Bénite, Auvergne-Rhône-Alpes, 69495
Duplicate_CHU de la miletrie /ID# 25906
Poitiers, Poitou-Charentes, 86021
CHU Reims - Hôpital Robert Debre /ID# 37064
Reims, Marne, 51092
Hôpital Charles-Nicolle /ID# 22845
Rouen, 76000
CHU de SAINT ETIENNE - Hopital Nord /ID# 27942
Saint Priest EN Jarez, Pays de la Loire Region, 42270
Austria11 sites
Medizinische Universitaet Graz /ID# 24263
Graz, Styria, 8010
Duplicate_Medizinische Universitat Innsbruck,Universitatsklinik fur Innere Mediz /ID# 22844
Innsbruck, 6020
Kepler Universitaetsklinikum GmbH /ID# 27922
Linz, Upper Austria, 4021
Landeskrankenhaus Salzburg-Universitätsklinikum der PMU (LKH) /ID# 22843
Salzburg, 5020
Duplicate_University Hospital St. Polten /ID# 22842
Sankt Pölten, Lower Austria, 3100
Klinik Landstrasse /ID# 20603
Vienna, State of Vienna, 1030
Dr. Harald Maier /ID# 27921
Vienna, State of Vienna, 1060
Medizinische Universitaet Wien /ID# 18364
Vienna, State of Vienna, 1090
Medizinische Universitaet Wien /ID# 211020
Vienna, State of Vienna, 1090
Klinik Hietzing /ID# 17183
Vienna, State of Vienna, 1130
Klinikum Wels-Grieskirchen GmbH /ID# 17543
Wels, Upper Austria, 4600
Greece11 sites
General Hospital Andreas Syggros /ID# 22847
Athens, Attica, 16121
General Hospital Andreas Syggros /ID# 22848
Athens, Attica, 16121
General Hospital Andreas Syggros /ID# 25905
Athens, Attica, 16121
Duplicate_Hospital Errikos Ntynan /ID# 28272
Athens, 11526
Naval Hospital of Crete /ID# 22849
Crete, Chania, 73136
General Hospital of Giannitsa /ID# 27951
Giannitsá, 58100
University General Hospital of Heraklion PA.G.N.I /ID# 27954
Heraklion, Crete, 71500
General Hospital of Katerini /ID# 27953
Katerini, 60100
Duplicate_Papageorgiou General Hospital Thessaloniki /ID# 28232
Nea Efkarpia, Thessaloniki, 54603
Tzaneio general hospital of Piraeus /ID# 28237
Piraeus, Attica, 18536
Thessaloniki hospital for skin and venereal diseases- Ippokrateio Thessaloniki /ID# 37068
Thessaloniki, 54643
Netherlands10 sites
Centrum Oosterwal /ID# 18349
Alkmaar, 1817 MS
ZiekenhuisGroep Twente /ID# 18355
Almelo, 7609 PP
Academisch Medisch Centrum /ID# 22850
Amsterdam, 1105 AZ
Amphia Ziekenhuis /ID# 20461
Breda, 4818 CK
Duplicate_Duplicate_Oosterschelde Ziekenhuis /ID# 20462
Goes, 4462 RA
Spaarne Gasthuis /ID# 22851
Haarlem, 2035 RC
Dijklander Ziekenhuis /ID# 18354
Hoorn, North Holland, 1624 NP
Radboud Universitair Medisch Centrum /ID# 24265
Nijmegen, Gelderland, 6525 GA
Erasmus Medisch Centrum /ID# 24264
Rotterdam, South Holland, 3015 GD
Diaconessenhuis Voorburg /ID# 18868
Voorburg, 2275 CX
Czechia9 sites
Fakultni Nemocnice Brno /ID# 27927
Brno, 625 00
Fakultni nemocnice u sv. Anny v Brne /ID# 37062
Brno, 656 91
Fakultni nemocnice Hradec Kralove /ID# 40201
Hradec Králové, 500 05
Fakultni nemocnice Olomouc /ID# 27930
Olomouc, 779 00
Duplicate_Univ Hosp, Plzen, CZ /ID# 27924
Pilsen, 305 99
Duplicate_Vseobecna fakultni nemoc Praze /ID# 25907
Prague, 128 08
Duplicate_Vseobecna fakultni nemoc Praze /ID# 27933
Prague, 128 08
Vseobecna fakultni nemocnice v Praze /ID# 28269
Prague, 128 08
Krajska zdravotni a.s. Masarykova nemocnice v Usti nad Labem o.z. /ID# 27923
Ústí nad Labem, 401 13
Germany9 sites
Klinikum Ruhr Univ Bochum /ID# 40200
Bochum, 44791
Universitaetsklinikum Koeln /ID# 27950
Cologne, North Rhine-Westphalia, 50937
Universitaetsklinikum Frankfurt /ID# 19801
Frankfurt am Main, Hesse, 60590
Universitaetsklinik Heidelberg /ID# 20601
Heidelberg, Baden-Wurttemberg, 69120
Universitaetsklinikum Jena /ID# 19765
Jena, Thuringia, 07747
Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 22846
Kiel, Schleswig-Holstein, 24105
Universitaetsklinikum Leipzig /ID# 20604
Leipzig, Saxony, 04103
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz /ID# 37067
Mainz, 55131
Universitaetsklinikum Muenster /ID# 37066
Munster, Lower Saxony, 48149
Spain9 sites
Hospital Universitario Fundacion Alcorcon /ID# 20723
Alcorcón, Madrid, 28922
Hospital General Universitario de Alicante Doctor Balmis /ID# 20730
Alicante, 03010
Hospital Universitario Germans Trias i Pujol /ID# 17152
Badalona, Barcelona, 08916
Hospital Universitari Sagrat Cor - Grupo Quiron Salud /ID# 19767
Barcelona, 08029
Hospital Clinic de Barcelona /ID# 19803
Barcelona, 08036
Hospital Duran i Reynals /ID# 18348
L'Hospitalet de Llobregat, Barcelona, 08907
Hospital Universitario de la Princesa /ID# 18867
Madrid, 28006
Hospital Universitario 12 de Octubre /ID# 18365
Madrid, 28041
Hospital Clinico Universitario Lozano Blesa /ID# 19763
Zaragoza, 50009
United Kingdom7 sites
NHS Grampian /ID# 37069
Aberdeen, AB15 6RE
Cardiff & Vale University Health Board /ID# 40204
Cardiff, Wales, CF14 4XN
NHS Greater Glasgow and Clyde /ID# 27956
Glasgow, Scotland, G12 0XH
Leeds Teaching Hospitals NHS Trust /ID# 40202
Leeds, LS9 7TF
The Royal Free London NHS Foundation Trust /ID# 40205
London, London, City of, NW3 2QG
Guys and St Thomas NHS Foundation Trust /ID# 28273
London, London, City of, SE1 9RT
Northern Care Alliance NHS Group /ID# 40203
Manchester, M8 5RB
Denmark4 sites
Aarhus University Hospital /ID# 18357
Aarhus N, Central Jutland, 8200
Bispebjerg and Frederiksberg Hospital /ID# 24271
Copenhagen NV, Capital Region, 2400
Herlev Hospital /ID# 20602
Herlev, Capital Region, 2730
Hudklinikken /ID# 20729
Herning, 7400
Ireland1 site
St Vincent's University Hospital /ID# 43149
Elm Park, Dublin, D04 T6F4
Puerto Rico1 site
Dr. Reinaldo Rosario Med Offic /ID# 24328
San Juan, 00918
About this study
Official title: A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
The purpose of this study is to evaluate the long-term safety of Humira® in Adult Patients with Chronic Plaque Psoriasis (Ps).
Read the detailed description
ESPRIT is a 10 year registry of patients taking HUMIRA® for Psoriasis. Patients who volunteer to participate will be asked to provide information about their medical history and experiences with HUMIRA®. No registry specific testing will be performed. Patients will be asked to provide data on their experiences with HUMIRA® approximately every 6 months, or as determined by the study doctor. No drug will be provided as a result of participation in the registry. All treatment decisions are independent of participation in the registry.
- Conditions
- Chronic Plaque Psoriasis
- Keywords
- Psoriasis, Moderate Psoriasis, Severe Psoriasis, Chronic Plaque Psoriasis, Severe Chronic Plaque Psoriasis, Registry
- Medical subject headings
- Psoriasis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| 1 | This registry will evaluate the long-term safety and effectiveness of HUMIRA® as used in routine clinical practice. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Incidence of Serious Adverse Events
Incidence of Adverse Events is calculated upon all events that occur during registry, during exposure to HUMIRA® prior to entry of registry, and in Health Care Provider process.
Measured: Duration of study
Incidence of Adverse Events of Special Interest
Incidence of Adverse Events is calculated upon all events that occur during registry, during exposure to HUMIRA® prior to entry of registry, and in Health Care Provider process.
Measured: Duration of study
Adverse Events that lead to permanent discontinuation of HUMIRA®
Incidence of Adverse Events that lead to permanent discontinuation of HUMIRA® is calculated upon all events that lead to permanent discontinuation of HUMIRA® during registry, during exposure to HUMIRA® prior to entry of registry, and in Health Care Provider process.
Measured: Duration of study
Secondary outcomes (12)
Health Care Utilization
Measured: Duration of study
Work Productivity and Activity Impairment Questionnaire: Specific Health Problem
Measured: Duration of study
Patient Global Assessment
Measured: Duration of study
Patient Health Question-9
Measured: Duration of study
Medical Outcomes Social Activities Scale
Measured: Duration of study
Patient reported outcome - Dermatology Life Quality Index
Measured: Duration of study
Census
Measured: Duration of study
Psoriasis Impact and Experience
Measured: Duration of study
Illness Cognition
Measured: Duration of study
Insurance Status
Measured: Duration of study
Rosenberg Self-Esteem Scale
Measured: Duration of study
Physician's Global Assessment
Measured: Collected approximately every six months.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Dec 2008 (estimated)
- Study start26 Sep 2008
- Primary completion13 Feb 2023
- Study completion13 Feb 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Chronic Plaque PsoriasisStudies of the same condition, open and under way.
- More trials run by AbbVieThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 6,065 participants (actual)
Sponsor and investigators
- Lead sponsor
- AbbVie
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- ABBVIE INC., Study director, AbbVie
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00799877
- Sponsor's protocol ID
- P10-023
- Status last verified
- Mar 2024
- First submitted
- 26 Nov 2008
- Last updated
- 15 Mar 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Lynde CW, Alam MS, Ohson K, Gagne-Henley A, Avadisian M, Vender RB. Enhanced Effectiveness of Adalimumab Compared to Topical/Traditional Systemic Agents in the Treatment of Moderate to Severe Plaque Psoriasis: Results from a Canadian Observational Epidemiologic Study (COMPLETE-PS). Dermatol Ther (Heidelb). 2022 Apr;12(4):921-931. doi: 10.1007/s13555-022-00703-3. Epub 2022 Mar 14.
PubMed 35286612Menter A, Thaci D, Wu JJ, Abramovits W, Kerdel F, Arikan D, Guo D, Ganguli A, Bereswill M, Camez A, Valdecantos WC. Long-Term Safety and Effectiveness of Adalimumab for Moderate to Severe Psoriasis: Results from 7-Year Interim Analysis of the ESPRIT Registry. Dermatol Ther (Heidelb). 2017 Sep;7(3):365-381. doi: 10.1007/s13555-017-0198-x. Epub 2017 Aug 16.
PubMed 28815476
Study at a glance
From the registry record, last updated by the sponsor on 15 Mar 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
- ClinicalTrials.gov ID
- NCT00799877
- Acronym / sponsor ID
- P10-023
- Conditions
- Chronic Plaque Psoriasis
- Keywords
- Psoriasis, Moderate Psoriasis, Severe Psoriasis, Chronic Plaque Psoriasis, Severe Chronic Plaque Psoriasis, Registry
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 6,065 participants (actual)
- Lead sponsor
- AbbVieIndustry (pharma, biotech, devices)
- Study start
- 26 Sep 2008 (actual)
- Primary completion
- 13 Feb 2023 (actual)
- Study completion
- 13 Feb 2023 (actual)
- First posted
- 1 Dec 2008 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to evaluate the long-term safety of Humira® in Adult Patients with Chronic Plaque Psoriasis (Ps).
Detailed description
ESPRIT is a 10 year registry of patients taking HUMIRA® for Psoriasis. Patients who volunteer to participate will be asked to provide information about their medical history and experiences with HUMIRA®. No registry specific testing will be performed. Patients will be asked to provide data on their experiences with HUMIRA® approximately every 6 months, or as determined by the study doctor. No drug will be provided as a result of participation in the registry. All treatment decisions are independent of participation in the registry.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| 1 | – | –This registry will evaluate the long-term safety and effectiveness of HUMIRA® as used in routine clinical practice. |
Who may qualify
- Ages
- 18 to 99 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- primary care clinic, departments of dermatology
Key inclusion criteria (8 listed)
- An adult patient (18 years of age or older) with chronic plaque psoriasis who has been prescribed HUMIRA® therapy according to the local product labeling and meets one of the following criteria:
- OR
- Patient is willing to consent to data being collected and provided to AbbVie;
- Patient is capable of and willing to give written informed consent and to comply with the requirements of the registry.
Key exclusion criteria (1 listed)
- Patient should not be enrolled if he/she cannot be treated in accordance with the local product label.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Incidence of Serious Adverse Events
Time frame: Duration of study
Incidence of Adverse Events is calculated upon all events that occur during registry, during exposure to HUMIRA® prior to entry of registry, and in Health Care Provider process.
Incidence of Adverse Events of Special Interest
Time frame: Duration of study
Incidence of Adverse Events is calculated upon all events that occur during registry, during exposure to HUMIRA® prior to entry of registry, and in Health Care Provider process.
Adverse Events that lead to permanent discontinuation of HUMIRA®
Time frame: Duration of study
Incidence of Adverse Events that lead to permanent discontinuation of HUMIRA® is calculated upon all events that lead to permanent discontinuation of HUMIRA® during registry, during exposure to HUMIRA® prior to entry of registry, and in Health Care Provider process.
12 secondary outcomes
Health Care Utilization
Time frame: Duration of study
Work Productivity and Activity Impairment Questionnaire: Specific Health Problem
Time frame: Duration of study
Patient Global Assessment
Time frame: Duration of study
Patient Health Question-9
Time frame: Duration of study
Medical Outcomes Social Activities Scale
Time frame: Duration of study
Patient reported outcome - Dermatology Life Quality Index
Time frame: Duration of study
Census
Time frame: Duration of study
Psoriasis Impact and Experience
Time frame: Duration of study
Illness Cognition
Time frame: Duration of study
Insurance Status
Time frame: Duration of study
Rosenberg Self-Esteem Scale
Time frame: Duration of study
Physician's Global Assessment
Time frame: Collected approximately every six months.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Mar 2024.
- Derived from this study: PubMed 35286612Lynde CW, Alam MS, Ohson K, Gagne-Henley A, Avadisian M, Vender RB. Enhanced Effectiveness of Adalimumab Compared to Topical/Traditional Systemic Agents in the Treatment of Moderate to Severe Plaque Psoriasis: Results from a Canadian Observational Epidemiologic Study (COMPLETE-PS). Dermatol Ther (Heidelb). 2022 Apr;12(4):921-931. doi: 10.1007/s13555-022-00703-3. Epub 2022 Mar 14.
- Derived from this study: PubMed 28815476Menter A, Thaci D, Wu JJ, Abramovits W, Kerdel F, Arikan D, Guo D, Ganguli A, Bereswill M, Camez A, Valdecantos WC. Long-Term Safety and Effectiveness of Adalimumab for Moderate to Severe Psoriasis: Results from 7-Year Interim Analysis of the ESPRIT Registry. Dermatol Ther (Heidelb). 2017 Sep;7(3):365-381. doi: 10.1007/s13555-017-0198-x. Epub 2017 Aug 16.
Related trials for Chronic Plaque Psoriasis
RecruitingPhase 4
An Open Label Trial to Evaluate Efficacy and Safety of Roflumilast 0.3% Cream for Chronic Plaque and Nail Psoriasis
Chronic Plaque Psoriasis, Nail Psoriasis
RecruitingPhase 2
Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation?
Psoriasis
RecruitingObservational study
Serum Substance P, Neuropathic Pain, and Central Sensitization Across Treatment Groups in Chronic Plaque Psoriasis
Chronic Plaque-type Psoriasis
Active, not recruitingPhase 3
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants
Psoriasis
Not yet recruitingPhase 2
Comparative Study on Unani Formulation Vs Active Control in Plaque Psoriasis
Chronic Plaque Psoriasis, Plaque Psoriasis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
ABBVIE INC. study director
AbbVie
339 sites in 14 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Chronic Plaque Psoriasis, run by AbbVie at 339 sites in 14 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 339 sites in United States, Canada, France, Austria, Greece and 9 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Incidence of Serious Adverse Events (time frame: Duration of study). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00799877, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Mar 2024.